Please enable JavaScript.
Coggle requires JavaScript to display documents.
(Drugs Used in the Treatment of Gastrointestinal Diseases) - Coggle Diagram
Drugs Used in the Treatment of Gastrointestinal Diseases
Physiology of Gastric Secretion
• Parietal Cells
Secrete up to 2L acid/day
Optimal pH for pepsin: 1.8–3.5
• H+/K+ ATPase (Proton Pump)
Exchanges H+ for K+
Stimulated by ACh, histamine, gastrin
• Inhibition by Somatostatin
Released when pH < 3
Inhibits parietal cells + histamine/gastrin release
• Phases of Acid Secretion
Cephalic: ACh from thought/smell of food
Gastric: Food stretch → gastrin release
Intestinal: Chyme triggers negative feedback
Peptic Ulcer Disease
• Causes
H. pylori
(most common)
NSAIDs, alcohol, stress, smoking
• Zollinger-Ellison Syndrome (Gastrinoma)
Tumor → excess gastrin → ulcers + diarrhea
• Symptoms
Burning pain, bloating, nausea
Severe: black stool, vomiting blood, weight loss
• Complications
GI bleeding
Perforation
Cancer (
H. pylori
-related)
Drug Classes & Their Use in GI Diseases
3.1 Antacids
• Types
Aluminum hydroxide (constipation)
Magnesium hydroxide (diarrhea)
Calcium carbonate (acid rebound)
Sodium bicarbonate (metabolic alkalosis risk)
• Combination Products
Balanced AE profile
Minimize aluminum absorption
• Adverse Effects
Constipation/diarrhea
Metabolic alkalosis
Renal insufficiency contraindicated
3.2 H₂ Receptor Antagonists
• Examples
Cimetidine, Ranitidine, Famotidine, Nizatidine
• Mechanism
Block histamine → ↓ cAMP → ↓ acid
• Uses
GERD, stress gastritis (IV), mild peptic ulcer
• Adverse Effects
Headache, fatigue, CNS effects (IV cimetidine)
Endocrine effects (↑ prolactin, ↓ estradiol)
• Drug Interactions
Cimetidine inhibits CYP enzymes
3.3 Proton Pump Inhibitors (PPIs)
• Examples
Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
• Mechanism
Irreversible inhibition of H⁺/K⁺ ATPase
• Uses
GERD (first-line), peptic ulcer, Zollinger-Ellison, GI bleed prophylaxis
• Adverse Effects
Headache, abdominal pain, B12 deficiency
↑ infection risk, ↑ gastrin, ECL cell hyperplasia
• Drug Interactions
↓ absorption of digoxin, ketoconazole
3.4 Mucosal Protective Agents
• Sucralfate
Forms protective layer over ulcers
Use: Peptic ulcer, stress gastritis
AE: Constipation, aluminum toxicity (renal failure)
3.5 Anti-
H. pylori
Therapy
• Triple Therapy
PPI + Clarithromycin + Amoxicillin / Metronidazole
• Quadruple Therapy
PPI + Bismuth subsalicylate + Metronidazole + Tetracycline
• Side Effects
GI upset, metallic taste
Risk of antibiotic resistance
3.6 Laxatives
• Bulk-forming
Psyllium, methylcellulose
AE: Bloating, flatulence
• Osmotic
Polyethylene glycol, lactulose, Mg salts
AE: Dehydration, electrolyte imbalance
• Stimulant
Senna, cascara
AE: Dependency, melanosis coli
• Stool Softeners
Docusate
AE: Minimal; safe long-term
3.7 Antidiarrheal Agents
• Opioid Agonists
Loperamide, diphenoxylate
MOA: Decrease motility, increase water absorption
AE: Constipation, CNS effects (diphenoxylate)
• Adsorbents
Kaolin-pectin, bismuth subsalicylate
AE: Salicylate toxicity (bismuth in large doses)
• Somatostatin Analogs
Octreotide
MOA: Inhibits secretions and motility
Use: Secretory diarrhea (carcinoid, AIDS, dumping syndrome)
AE: Gallstones, glucose intolerance
3.8 Serotonergic Agents for GI Motility
• 5-HT₄ Agonists
Tegaserod
MOA: Enhances Ach & CGRP release → ↑ motility
Use: Chronic constipation, IBS-C
AE: Diarrhea, expensive
• 5-HT₃ Antagonists
Alosetron
MOA: Blocks sensory signals in gut → ↓ visceral pain
Use: IBS-D (female-predominant)
AE: Ischemic colitis (black box warning), severe constipation
3.9 Antiemetics
• 5-HT₃ Antagonists
Ondansetron, Granisetron
Use: chemo/radiotherapy-induced nausea, post-op
AE: Headache, constipation
• NK₁ Antagonists
Aprepitant
Use: Delayed emesis
AE: Fatigue, hiccups
• Dopamine Antagonists
Prochlorperazine, Promethazine
Use: Motion sickness, chemotherapy
AE: Extrapyramidal symptoms, sedation
3.10 Antiprotozoals
• Metronidazole
Use: Amebiasis, Giardiasis, Trichomoniasis
AE: Metallic taste, headache
• Tinidazole
Similar to metronidazole but better tolerated
• Chloroquine
Use: Intestinal amebiasis (luminal)
3.11 Anthelmintics
• Mebendazole
Broad-spectrum; inhibits microtubules
• Niclosamide
Interferes with energy metabolism
• Praziquantel
Increases Ca²⁺ permeability → spastic paralysis
Use: Flukes, schistosomes
AE: Dizziness, headache
3.12 Antiviral Agents for GI Viruses
• Ganciclovir / Foscarnet
Use: CMV gastroenteritis (immunocompromised)
AE: Bone marrow suppression, renal toxicity
• Acyclovir
Use: HSV esophagitis
AE: Nephrotoxicity
3.13 Viral Gastroenteritis
• Rotavirus
Vaccine available, affects infants
• Norovirus
Highly contagious, outbreaks
• Adenovirus
Affects infants and immunocompromised
• CMV
Severe in neonates and immunosuppressed
• HSV
Can cause esophagitis in immunosuppressed
Special Notes
• Drug Interactions
Cimetidine inhibits CYP enzymes
PPIs affect absorption of digoxin, ketoconazole
• Adverse Effects to Monitor
Vitamin B12 deficiency (PPIs)
Long-term ↑ gastrin levels (PPIs)
Neurological side effects (Metronidazole, Cimetidine)
• Patient Education
Lifestyle changes before laxatives
Avoid alcohol with Metronidazole
Take PPIs on empty stomach